Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$229M Sell
2,016,597
-83,065
-4% -$9.52M 0.22% 83
2023
Q4
$231M Sell
2,099,662
-648,639
-24% -$64.8M 0.22% 81
2023
Q3
$266M Buy
2,748,301
+87,370
+3% +$9.18M 0.27% 66
2023
Q2
$290M Buy
2,660,931
+7,758
+0.3% +$827K 0.29% 61
2023
Q1
$269M Buy
2,653,173
+116,350
+5% +$12.3M 0.27% 63
2022
Q4
$279M Buy
2,536,823
+70,563
+3% +$7.31M 0.3% 64
2022
Q3
$239M Sell
2,466,260
-74,001
-3% -$7.89M 0.27% 65
2022
Q2
$276M Buy
2,540,261
+100,445
+4% +$11.4M 0.29% 64
2022
Q1
$289M Buy
2,439,816
+53,648
+2% +$6.65M 0.25% 73
2021
Q4
$336M Sell
2,386,168
-29,686
-1% -$3.8M 0.18% 90
2021
Q3
$285M Buy
2,415,854
+205,708
+9% +$25.3M 0.16% 117
2021
Q2
$259M Sell
2,210,146
-1,125,208
-34% -$131M 0.14% 143
2021
Q1
$400M Buy
3,335,354
+744,291
+29% +$88.2M 0.2% 85
2020
Q4
$284M Buy
2,591,063
+16,890
+0.7% +$1.84M 0.14% 138
2020
Q3
$280M Buy
2,574,173
+3,908
+0.2% +$396K 0.17% 107
2020
Q2
$235M Sell
2,570,265
-318,689
-11% -$28.8M 0.17% 110
2020
Q1
$228M Sell
2,888,954
-209,716
-7% -$17.5M 0.2% 99
2019
Q4
$269M Buy
3,098,670
+126,424
+4% +$10.6M 0.2% 86
2019
Q3
$249M Buy
2,972,246
+720,791
+32% +$61.2M 0.21% 78
2019
Q2
$189M Buy
2,251,455
+33,711
+2% +$2.65M 0.17% 106
2019
Q1
$177M Buy
2,217,744
+59,211
+3% +$4.41M 0.16% 106
2018
Q4
$156M Sell
2,158,533
-76,935
-3% -$5.41M 0.16% 113
2018
Q3
$164M Buy
2,235,468
+357,895
+19% +$23.5M 0.15% 118
2018
Q2
$115M Sell
1,877,573
-188,065
-9% -$11.4M 0.11% 162
2018
Q1
$124M Sell
2,065,638
-239,632
-10% -$14.4M 0.12% 168
2017
Q4
$132M Sell
2,305,270
-203,863
-8% -$11.3M 0.12% 149
2017
Q3
$134M Sell
2,509,133
-451,513
-15% -$22.7M 0.13% 150
2017
Q2
$144M Sell
2,960,646
-205,089
-6% -$9.28M 0.14% 128
2017
Q1
$141M Sell
3,165,735
-605,468
-16% -$26.2M 0.13% 153
2016
Q4
$145M Sell
3,771,203
-344,109
-8% -$13.6M 0.14% 132
2016
Q3
$174M Buy
4,115,312
+296,549
+8% +$12.7M 0.16% 105
2016
Q2
$150M Buy
3,818,763
+925,709
+32% +$36.8M 0.17% 112
2016
Q1
$121M Sell
2,893,054
-185,206
-6% -$7.34M 0.15% 136
2015
Q4
$138M Buy
3,078,260
+468,837
+18% +$20.7M 0.16% 130
2015
Q3
$105M Sell
2,609,423
-87,854
-3% -$4.14M 0.13% 161
2015
Q2
$132M Sell
2,697,277
-363,028
-12% -$17.4M 0.13% 156
2015
Q1
$142M Sell
3,060,305
-1,090,144
-26% -$50.1M 0.14% 142
2014
Q4
$187M Buy
4,150,449
+722,463
+21% +$31.5M 0.17% 121
2014
Q3
$143M Buy
3,427,986
+172,864
+5% +$7.31M 0.12% 166
2014
Q2
$133M Buy
3,255,122
+352,072
+12% +$13.8M 0.11% 179
2014
Q1
$112M Sell
2,903,050
-406,381
-12% -$15.7M 0.11% 164
2013
Q4
$127M Buy
3,309,431
+225,328
+7% +$8.31M 0.12% 151
2013
Q3
$102M Sell
3,084,103
-471,551
-13% -$16.5M 0.1% 166
2013
Q2
$124M Buy
+3,555,654
New +$130M 0.13% 135

Other funds holding ABT

Credit Suisse's ABT Position: Q1 2024 in Review

Credit Suisse reduced its Abbott (ABT) stake by 4% in Q1 2024, selling an estimated $9.52M and leaving 2,016,597 shares worth $229M. The position accounts for 0.22% of the portfolio, ranked #83.

Credit Suisse first reported a position in ABT in Q2 2013 and has held it in 44 quarters since. The position peaked at $400M in Q1 2021. 2,904 funds tracked by Wall St. Rank hold ABT as of Q1 2024.

  • Credit Suisse held 2,016,597 shares of Abbott worth $229M as of Q1 2024.
  • Credit Suisse sold 83,065 Abbott shares in Q1 2024, an estimated $9.52M.
  • Abbott made up 0.22% of Credit Suisse's portfolio in Q1 2024, its #83 holding.
  • Credit Suisse first reported a position in Abbott in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Abbott position peaked at $400M in Q1 2021.
  • 2,904 funds tracked by Wall St. Rank held Abbott as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.